Maryland gets an A on ‘Rheumatic Disease Report Card’September 6, 2018Business of MedicineRheumatology
Infliximab biosimilar only moderately less expensive in Medicare Part DSeptember 6, 2018GastroenterologyRheumatologyDermatology
Is fibromyalgia one disorder – or two?July 24, 2018RheumatologyBusiness of MedicineEndocrinologyGeriatricsMental HealthMixed TopicsNeurology
Nerve growth factor inhibitor shows phase 3 efficacy in osteoarthritisJuly 19, 2018OsteoarthritisRheumatologyPain
Malpractice and pain managementJuly 17, 2018PainBusiness of MedicineOpioid Resource CenterAddiction MedicineNeurologyRheumatology
